Hemodialysis catheter is a soft and flexible tube manufactured from a bio-compatible material such as silicone or polyurethane. It contains two types of lumens (flexible tubular passage) for exchange of blood, which are colored in red and blue for clear identification during dialysis process. The red colored lumen (atrial lumen) draws blood from patient and transfers it to the dialysis machine for filtration, the blue colored lumen (venous lumen) returns the blood to patient after filtration from dialysis machine. The global hemodialysis catheters market was valued at $663 million in 2016, and is estimated to reach at $926 million by 2023, registering a CAGR of 4.8% from 2017 to 2023.
Increase in number of patients suffering from end-stage renal disease (ESRD) and surge in prevalence of chronic kidney disorders (CKD) drive the growth of the hemodialysis catheter market. In addition, technological advancements in dialysis equipment and catheter technology are expected to fuel the market growth. However, limitations in medical reimbursement for dialysis procedures and low awareness about kidney-related disorders in underdeveloped countries hinder the market growth.
The hemodialysis catheters market is segmented based on product, tip configuration, material, end user, and geography. On the basis of product, the market is segmented into cuffed tunneled catheters, non-cuffed tunneled catheters and non-tunneled catheters. By material, the market is categorized into silicone, polyurethane. Depending on tip configuration, it is classified into step-tip catheters, split-tip catheters, and symmetric catheters. According to end user, it is fragmented into hospitals, clinics/dialysis centers and home dialysis. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
KEY PLAYERS PROFILED IN THE REPORT
KEY MARKET SEGMENTS
By Tip Configuration
The other players in the value chain include (profiles not included in the report)
Fertility Services Market by Procedure (IVF with ICSI, Surrogacy, IVF without ICSI, IUI, and Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Fertility services are treatments, which aid in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. The global fertility services market was valued at $16,761 million ...
February 2018 | $5370 |View Details>>
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer ...
February 2018 | $4880 |View Details>>
This report studies the IV Flush Syringe market. Health care professionals use IV flush syringes to clear out patients’ catheters and intravenous lines to ensure the tubes are sterile. Nurse Assist, a Texas-based medical device manufacturer, recalled all of its Normal Saline IV Flush Syringes in 2016 after ...
February 2018 | $4880 |View Details>>
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have ...
February 2018 | $3480 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2018 © Copyright Big Market Research